Optimizing Image Quality in Obese Patients Undergoing Coronary Computed Tomography (CT) Angiography
NCT ID: NCT00468195
Last Updated: 2012-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
175 participants
OBSERVATIONAL
2007-05-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Imaging-based Diagnosis of Diffuse Coronary Artery Disease and Quantification of Cardiac Remodeling in Obesity
NCT03046823
Evaluate the Effectiveness and Cost of Stress Cardiac Magnetic Resonance Imaging (MRI) for Non-invasive Evaluation of Lesions Discovered on Computed Tomography Angiography (CCTA)
NCT00538460
Evaluating New Radiation Techniques for Cardiovascular Imaging
NCT01621594
Quantitative Analysis of Functional CT Imaging of Coronary Atherosclerosis
NCT04986410
Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
NCT04394637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recent advances in multi-detector computed tomography angiography has made a noninvasive technique of diagnosis of coronary artery disease possible. Multi-detector computed tomography (MDCT) offers great promise as a risk stratification tool in patients with suspected CAD. It has been demonstrated in a multitude of accuracy studies to have a negative predictive value averaging over 95%. This leads to the hypothesis that a negative MDCT may preclude the need for invasive testing. The purpose of this study is to develop an optimal way to image obese patients without presenting an increased risk.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age greater than 18 years
3. Ability to provide informed consent
4. Scheduled to undergo coronary CTA -
Exclusion Criteria
2. Renal insufficiency (creatinine ≥1.6) or renal failure requiring dialysis.
3. Inability or refusal to provide informed consent.
4. Pregnancy or unknown pregnancy status.
5. Age less than 18 years.
6. Patients with known allergy to iodinated contrast.
8\. Computed tomography imaging, or contrast administration, within the past 48 hours.
9.Known asthma or reactive airway disease.
\-
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
William Beaumont Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kavitha Chinnaiyan
Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kavitha Chinnaiyan, MD
Role: PRINCIPAL_INVESTIGATOR
William Beaumont Hospitals
Gilbert Raff, MD
Role: STUDY_DIRECTOR
William Beaumont Hospitals
James Goldstein, MD
Role: STUDY_CHAIR
William Beaumont Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
William Beaumont Hospital
Royal Oak, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.